Med-X, Inc. (MXRX)

Med-X Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Revenue	1.4	1.01	1.03
Revenue Growth (YoY)	-	-2.26%	-
Cost of Revenue	-	0.88	0.87
Gross Profit	0.23	0.13	0.16
Selling, General & Admin	-	2.15	1.63
Other Operating Expenses	0	3.21	2.07
Operating Expenses	-	5.36	3.69
Operating Income	-7.57	-5.23	-3.53
Interest Expense / Income	0	-0	0.01
Other Expense / Income	-	-0.32	-
Pretax Income	-7.58	-4.91	-3.54
Net Income	-7.58	-4.91	-3.54
Free Cash Flow	-5.49	-4.45	-3.31
Gross Margin	16.08%	12.94%	15.79%
Operating Margin	-541.25%	-517.47%	-341.60%
Profit Margin	-541.35%	-485.68%	-342.54%
Free Cash Flow Margin	-392.10%	-440.57%	-319.75%
EBITDA	-7.53	-4.86	-3.42
EBITDA Margin	-538.40%	-480.59%	-330.68%
Depreciation & Amortization	0.04	0.05	0.11
EBIT	-7.57	-4.91	-3.53
EBIT Margin	-541.25%	-485.84%	-341.60%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).